Your browser doesn't support javascript.
loading
Corrigendum: Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis.
Du, Xiaoli; Tao, Qianqian; Du, Hongxia; Zhao, Zhenbang; Dong, Yu; He, Shuang; Shao, Rui; Wang, Yule; Han, Wenrun; Wang, Xintong; Zhu, Yan.
Afiliação
  • Du X; Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Tao Q; Department of Pharmacy, Inner Mongolia Medical College, Hohhot, China.
  • Du H; Tianjin International Joint Academy of Biomedicine, Tianjin, China.
  • Zhao Z; Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Dong Y; Tianjin International Joint Academy of Biomedicine, Tianjin, China.
  • He S; Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Shao R; Tianjin International Joint Academy of Biomedicine, Tianjin, China.
  • Wang Y; Department of Pharmacy, Inner Mongolia Medical College, Hohhot, China.
  • Han W; Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Wang X; Department of Pharmacy, Inner Mongolia Medical College, Hohhot, China.
  • Zhu Y; Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Front Pharmacol ; 12: 814501, 2021.
Article em En | MEDLINE | ID: mdl-35173612
ABSTRACT
[This corrects the article DOI 10.3389/fphar.2021.638298.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China